The use of intravitreal corticosteroids in the management of macular oedema has recently gained widespread acceptance. New long-acting steroid preparations and methods of delivery have facilitated the use of these new modalities. This review describes the various types of macular oedema for which this therapeutic option is used and the results.
No takes yet. Share an insight, caveat, or question.
Sivaprasad et al. (2006) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: